- Home » News and Events
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Publishes Fifth Annual Corporate Responsibility Report
Mar 7, 2024
The 2023 Corporate Responsibility Report highlights progress across every pillar of Catalent’s corporate responsibility strategy – People, Environment, and Community.
Novo Holdings to Acquire Catalent
Feb 5, 2024
Catalent and Novo Holdings have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.
Catalent Announces Addition of Potent Capsule Filling Capabilities for Inhaled Dry Powders at its Boston, MA USA Facility
Feb 2, 2024
These upgrades, including the addition of capacity for both development and commercial spray drying, now position Catalent as the CDMO with the largest GMP capacity for capsule spray-dried and carrier-based inhaled powders.
Catalent Commits to Reducing Greenhouse Gas Emissions by 2030
Jan 25, 2024
The company also committed to engaging with its suppliers such that 70% of their emissions will have reduction goals aligned with science-based targets by the end of fiscal 2028.
Catalent Appoints David McErlane as Biologics Segment Leader
Sep 18, 2023
Mr. McErlane will lead all of Catalent’s Biologics businesses and global service offerings – including development, drug substance manufacturing, drug product fill-and-finish, cell and gene therapy, and analytical services.
Catalent Appoints Lisa Evoli Senior Vice President and Chief Human Resources Officer
Aug 1, 2023
She will be responsible for leading Catalent’s global human resources strategy, including talent acquisition, leadership development, diversity and inclusion, compensation and benefits, HR operations and technology, and performance management.
Catalent Appoints Matti Masanovich Senior Vice President & Chief Financial Officer
Jun 20, 2023
Mr. Masanovich will have responsibility for all aspects of Catalent’s global financial operations, including financial planning and analysis, controllership, public reporting and investor relations, capital markets activities, bill payment and collection, tax, and treasury.
Catalent and JLABS Symposium to Discuss Accelerated Development and Manufacturing of Biologics
Jun 7, 2023
Experts and speakers from Catalent and JLABS will be joined by speakers from Johnson & Johnson and Cardiff Advisory LLC.
Catalent Expands OneBio® Suite for Integrated Development, Manufacturing and Supply Across Biologic Modalities
Jun 5, 2023
OneBio Suite offers customers an integrated service to accelerate programs from development to manufacturing, including fill/finish and packaging, and support for clinical supply and commercial launch.
DCAT Week 2024
Date: March 18-21, 2024
17th Annual Bio Supply Management Alliance (BSMA) Summit
Date: March 20-21, 2024
Partnering to Achieve Successful Development and GMP Compliance for Cell Therapies
Date: March 27, 2024
AACR – American Association for Cancer Research
Date: April 5-10, 2024
Cell & Gene Meeting on the Med
Date: April 9-11, 2024
German Biotech Days
Date: April 16-17, 2024
in-cosmetics Global 2024
Date: April 16-18, 2024
Interphex US
Date: April 16-18, 2024
Anglonordic Life Science Conference
Date: April 17-18, 2024
Nicholas Hall’s 34th CHC European Conference
Date: April 17-19, 2024
Extractables and Leachables Summit
Date: April 18-19, 2024
Navigating Early Drug Development Journey: Strategies for Successful Phase 1
Date: April 18, 2024
GCSG 2024 US Conference
Date: April 21-24, 2024
Swiss Biotech Days
Date: April 22-23, 2024
12th Alzheimer’s & Parkinson’s Drug Development Summit
Date: April 23-25, 2024
Clinical Outsourcing Group (COG) New England 2024
Date: April 23-24, 2024
Road to IND: Accelerating Viral-Vector Based Gene Therapies to Patients
Date: April 24, 2024
ASGCT
Date: May 7-11, 2024